Stella Maris, LLC

Stella Maris is addressing the prevalent issue of mitochondrial damage diseases (MDDs), including chronic fatigue syndrome, autism and Alzheimer’s disease, which affect tens of millions of people worldwide. The nutritional needs of these patients are not being met with current treatment. Stella Maris has patent-pending generally regarded as safe (GRAS) medical food formulations based on clinical data aimed at managing the nutritional needs of MDD patients.